{
    "id": 19877,
    "fullName": "SYK positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "SYK positive indicates the presence of the SYK gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 6850,
        "geneSymbol": "SYK",
        "terms": [
            "SYK",
            "p72-Syk"
        ]
    },
    "variant": "positive",
    "createDate": "03/18/2016",
    "updateDate": "05/15/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5231,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, R406 inhibited proliferation and migration and increased apoptosis of SYK-positive primary multiple myeloma cells in culture (PMID: 26251761).",
            "molecularProfile": {
                "id": 20312,
                "profileName": "SYK positive"
            },
            "therapy": {
                "id": 3782,
                "therapyName": "Tamatinib",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4933,
                    "pubMedId": 26251761,
                    "title": "Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26251761"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5232,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Piceatannol inhibited proliferation and migration and increased apoptosis of SYK-positive primary multiple myeloma cells in culture (PMID: 26251761).",
            "molecularProfile": {
                "id": 20312,
                "profileName": "SYK positive"
            },
            "therapy": {
                "id": 3783,
                "therapyName": "Piceatannol",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4933,
                    "pubMedId": 26251761,
                    "title": "Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26251761"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5233,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BAY 61-3606 inhibited proliferation and migration and increased apoptosis of SYK-positive primary multiple myeloma cells in culture (PMID: 26251761).",
            "molecularProfile": {
                "id": 20312,
                "profileName": "SYK positive"
            },
            "therapy": {
                "id": 2665,
                "therapyName": "BAY 61-3606",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4933,
                    "pubMedId": 26251761,
                    "title": "Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26251761"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20312,
            "profileName": "SYK positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}